Brief: Sedana Medical Q4 Sales SEK 49.2 Million
13/02/2025 06:01
Feb 13 (Reuters) - Sedana Medical Q4 EBIT margin -22%. * Q4 adjusted EPS SEK 0.09 * Q4 EBITDA SEK -5.3 million * Q4 cash flow from operating activities SEK 7.3 million * Q4 net income SEK 8.5 million
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln